DenseBreast-info, Inc. (DB-I) has shared its public comments on the FDA’s proposed changes to the Mammography Quality Standards Act of 1992 (MQSA). The FDA first announced its efforts to amend the MQSA back in March.

Leading imaging vendors regularly bribe government officials in China to get their products in area hospitals, according to an in-depth report from the New York Times.

Canon Medical Systems USA has received FDA approval for its deep convolutional neural network (DCNN) image reconstruction technology for CT scanning.

IBM, along with KPMG, Merck and Walmart have been selected by the FDA to participate in a blockchain project that aims to improve the drug supply chain.

Emergency department (ED) visits for suspected urolithiasis are on the rise in the United States, according to a new study published in the Journal of the American College of Radiology. And more of those patients are receiving CT of the abdomen and pelvis (CTAP) as a part of their treatment.

President Trump is promising a new healthcare plan for the nation in recent media interviews, though there have been scant details so far.

A culture of corruption allows giant companies like General Electric, Siemens, Philips and Toshiba to bribe Chinese government and hospital officials into purchasing expensive medical equipment, including imaging modalities, according to a lengthy piece published by the New York Times.

A San Francisco-based startup that uses a proprietary machine-learning platform to identify the care needs of covered employees has raised $205 million to “address fundamental health insurance service issues that plague U.S. consumers and employers alike.”